What is the BBIO stock price prediction for next 2 weeks?

According to our price prediction algorithm,BridgeBio Pharma, Inc. (BBIO) price will be around $81.96 in the next 2 weeks. This means it will increase by 2.496123061530773 from the last closing price. This prediction may vary from other time period filters for BBIO stock.

What can be the highest Possible price of BBIO stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BBIO can achieve the highest price of $84.92 which is 6.207964856705161 higher than last closing price. This prediction may vary from other time period filters for BBIO stock.

What can be the lowest Possible price of BBIO stock in next 2 weeks?

As per the forecast and algorithmic analysis, BBIO stock price can be as low as $78.91 which is -1.3128079059029745 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for BBIO stock.

Will BBIO stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that BBIO stock will gain2.496123061530773 in the next 2 weeks. This prediction may vary from other time period filters for BBIO stock.

What is BBIO stock last closing price?

Last closing price of BBIO stock was $79.96.

What is BBIO stock price prediction?

BBIO stock price prediction means predicting the future closing prices of BBIO stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BBIO stock in a certain time period.

How we predict BBIO stock future prices?

If you are searching for BBIO stock forecast, analysis or price prediction, then you might be wondering what BridgeBio Pharma, Inc. (BBIO) will do in the future. Our BBIO price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BBIO price prediction will likely answer most of your questions.

How frequent we update BBIO stock predictions?

We are updating the forecasts for the BBIO stock on daily basis.

Is using ML forecasting for BBIO stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BBIO stock same for all the time periods?

No, the prediction for BBIO stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

BridgeBio Pharma, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$79.96-3.02%Since 2 Weeks

Predicted Price$81.962.5%For 2 Weeks

Upper Predicted Price$84.926.21%For 2 Weeks

Lower Predicted Price$78.91-1.31%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BBIO will rise by +2.50% over the next 2 Weeks and hit $81.96 by Monday, August 17, 2026. In that time frame, BBIO's share price is expected to range between $78.91 and $84.92.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 17, 2026	78.91	81.96	84.92
Aug 14, 2026	79.71	82.72	85.73
Aug 13, 2026	79.13	81.99	84.80
Aug 12, 2026	77.88	80.78	83.80
Aug 11, 2026	78.46	81.23	84.16
Aug 10, 2026	77.88	80.80	83.40
Aug 7, 2026	78.79	81.57	84.51
Aug 6, 2026	78.21	80.83	83.78
Aug 5, 2026	76.68	79.63	82.59
Aug 4, 2026	77.01	80.07	82.98

BBIO shares fell -0.16% in Monday, August 3, 2026's trading session, dropping from a previous close of $80.09 to move at $79.96. The stock demonstrated notable intraday movement (see BBIO's key stats for a full breakdown), fluctuating between $78.82 and $81.23, a +3.06% trading range. While recent weeks have seen some volatility, BBIO has managed to secure a -3.02% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 1.34M shares changing hands, 796.63K fewer than the previous session. This amounted to $106.82M in total market activity.

Will BBIO Continue Its Upward Trend?

According to analyst ratings and projections for BBIO, BridgeBio Pharma, Inc. shares are anticipated to increase by +5.85%, potentially reaching $84.92 per share by August 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for BBIO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 20 positive trading days within the past 30 sessions. Based on the BBIO stock forecast, now is a good time to buy BBIO stock because its current trading price is -2.44% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BBIO covering social and institutional perspectives.

BBIO Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BBIO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.49% to 53.49%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 54.25%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.07%, maintains a neutral outlook for the long term. Insights into BBIO's shareholder base show how institutional investors are positioning themselves during these momentum shifts

BridgeBio Pharma Short-Term Forecasts

BBIO Forecast For Next 5 Days

Our algorithm anticipates BridgeBio Pharma (BBIO) stock could hit $81.79 by Aug 10, 2026. This represents a +2.29% rise from today's price, following a +0.46% change over the past five days.

BBIO Forecast For Next 30 Days

Based on analysis of market trends, the outlook for BridgeBio Pharma, Inc. (BBIO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $83.61, which would mean a +4.56% increase from the current price of $79.96. Projections for this period range from a high of $88.71 to a low of $79.21.

BBIO Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for BridgeBio Pharma's price over the next three months point to a rise. BBIO stock is expected to peak at $92.11 on Nov 04, 2026 after potentially dipping to $74.84 on Aug 17, 2026. On average, BBIO is likely to trade around $82.83 in the coming 90 days.

BridgeBio Pharma Stock Forecast 2025

Based on our predictive models, BridgeBio Pharma (BBIO) is expected to trade between $74.84 and $93.51 throughout 2026. This would result in an average price of $84.89, potentially offering investors a +6.17% return from current levels.

BridgeBio Pharma, Inc. Monthly Forecast 2026–2027

August 2026

According to our latest forecast models, BridgeBio Pharma, Inc. (BBIO) is positioned to show a strong performance in August 2026. The price is predicted to move between $74.84 and $85.14, settling at an average of $80.01. This could translate to a +0.06% gain.

September 2026

Based on current market signals, BridgeBio Pharma, Inc. is projected to trend september 2026. We forecast a trading range from $76.93 to $88.70, with a likely average price of $83.31. Investors could expect a potential return of +4.19%.

October 2026

Our predictive algorithms indicate BridgeBio Pharma, Inc. stock may see a shift in October 2026. The expected range spans $79.05–$90.03, with an average target of $84.24. This represents a positive outlook and a possible gain of +5.35%.

November 2026

Analyzing established trends, BridgeBio Pharma, Inc. looks set to move in November 2026. Projections place the stock between $83.11 and $93.21, averaging around $88.06. This suggests a +10.13% gain from current levels.

December 2026

Market indicators suggest BridgeBio Pharma, Inc. could experience notable changes during December 2026. Prices could fluctuate within $83.02 to $93.51, with a midpoint forecast of $88.39. The stock might deliver a +10.54% gain.

January 2027

Forecasting for January 2027, models estimate that BridgeBio Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $81.88 and $92.18, averaging $87.27. This signals a positive trajectory with potential returns around +9.14%.

February 2027

According to our latest forecast models, BridgeBio Pharma, Inc. (BBIO) is positioned to show a strong performance in February 2027. The price is predicted to move between $84.62 and $96.06, settling at an average of $90.64. This could translate to a +13.36% gain.

March 2027

Based on current market signals, BridgeBio Pharma, Inc. is projected to trend march 2027. We forecast a trading range from $86.17 to $98.18, with a likely average price of $91.57. Investors could expect a potential return of +14.52%.

April 2027

Our predictive algorithms indicate BridgeBio Pharma, Inc. stock may see a shift in April 2027. The expected range spans $90.24–$99.84, with an average target of $95.28. This represents a positive outlook and a possible gain of +19.16%.

May 2027

Analyzing established trends, BridgeBio Pharma, Inc. looks set to move in May 2027. Projections place the stock between $89.39 and $100.45, averaging around $95.58. This suggests a +19.53% gain from current levels.

June 2027

Market indicators suggest BridgeBio Pharma, Inc. could experience notable changes during June 2027. Prices could fluctuate within $89.05 to $99.39, with a midpoint forecast of $94.45. The stock might deliver a +18.12% gain.

July 2027

Forecasting for July 2027, models estimate that BridgeBio Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $91.55 and $102.66, averaging $97.85. This signals a positive trajectory with potential returns around +22.37%.

August 2027

According to our latest forecast models, BridgeBio Pharma, Inc. (BBIO) is positioned to show a strong performance in August 2027. The price is predicted to move between $93.78 and $101.74, settling at an average of $97.88. This could translate to a +22.41% gain.

BBIO's history of dividends and stock splits also plays a role in long-term investor confidence.